اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدCOVID-19: A Survey on Public Medical Imaging Data Resources
45
0
0.0
(
0
)
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
This regularly updated survey provides an overview of public resources that offer medical images and metadata of COVID-19 cases. The purpose of this survey is to simplify the access to open COVID-19 image data resources for all scientists currently working on the coronavirus crisis.
قيم البحث
اقرأ أيضاً
The outbreak of novel coronavirus disease (COVID- 19) has claimed millions of lives and has affected all aspects of human life. This paper focuses on the application of deep learning (DL) models to medical imaging and drug discovery for managing COVI
D-19 disease. In this article, we detail various medical imaging-based studies such as X-rays and computed tomography (CT) images along with DL methods for classifying COVID-19 affected versus pneumonia. The applications of DL techniques to medical images are further described in terms of image localization, segmentation, registration, and classification leading to COVID-19 detection. The reviews of recent papers indicate that the highest classification accuracy of 99.80% is obtained when InstaCovNet-19 DL method is applied to an X-ray dataset of 361 COVID-19 patients, 362 pneumonia patients and 365 normal people. Furthermore, it can be seen that the best classification accuracy of 99.054% can be achieved when EDL_COVID DL method is applied to a CT image dataset of 7500 samples where COVID-19 patients, lung tumor patients and normal people are equal in number. Moreover, we illustrate the potential DL techniques in drug or vaccine discovery in combating the coronavirus. Finally, we address a number of problems, concerns and future research directions relevant to DL applications for COVID-19.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The disease presents with symptoms such as shortness of breath, fever, dry cough, and chronic fatigue, amongst others. Sometimes the symptoms of the dis
ease increase so much they lead to the death of the patients. The disease may be asymptomatic in some patients in the early stages, which can lead to increased transmission of the disease to others. Many studies have tried to use medical imaging for early diagnosis of COVID-19. This study attempts to review papers on automatic methods for medical image analysis and diagnosis of COVID-19. For this purpose, PubMed, Google Scholar, arXiv and medRxiv were searched to find related studies by the end of April 2020, and the essential points of the collected studies were summarised. The contribution of this study is four-fold: 1) to use as a tutorial of the field for both clinicians and technologists, 2) to comprehensively review the characteristics of COVID-19 as presented in medical images, 3) to examine automated artificial intelligence-based approaches for COVID-19 diagnosis based on the accuracy and the method used, 4) to express the research limitations in this field and the methods used to overcome them. COVID-19 reveals signs in medical images can be used for early diagnosis of the disease even in asymptomatic patients. Using automated machine learning-based methods can diagnose the disease with high accuracy from medical images and reduce time, cost and error of diagnostic procedure. It is recommended to collect bulk imaging data from patients in the shortest possible time to improve the performance of COVID-19 automated diagnostic methods.
The coronavirus disease, named COVID-19, has become the largest global public health crisis since it started in early 2020. CT imaging has been used as a complementary tool to assist early screening, especially for the rapid identification of COVID-1
9 cases from community acquired pneumonia (CAP) cases. The main challenge in early screening is how to model the confusing cases in the COVID-19 and CAP groups, with very similar clinical manifestations and imaging features. To tackle this challenge, we propose an Uncertainty Vertex-weighted Hypergraph Learning (UVHL) method to identify COVID-19 from CAP using CT images. In particular, multiple types of features (including regional features and radiomics features) are first extracted from CT image for each case. Then, the relationship among different cases is formulated by a hypergraph structure, with each case represented as a vertex in the hypergraph. The uncertainty of each vertex is further computed with an uncertainty score measurement and used as a weight in the hypergraph. Finally, a learning process of the vertex-weighted hypergraph is used to predict whether a new testing case belongs to COVID-19 or not. Experiments on a large multi-center pneumonia dataset, consisting of 2,148 COVID-19 cases and 1,182 CAP cases from five hospitals, are conducted to evaluate the performance of the proposed method. Results demonstrate the effectiveness and robustness of our proposed method on the identification of COVID-19 in comparison to state-of-the-art methods.
Early detection of the coronavirus disease 2019 (COVID-19) helps to treat patients timely and increase the cure rate, thus further suppressing the spread of the disease. In this study, we propose a novel deep learning based detection and similar case
recommendation network to help control the epidemic. Our proposed network contains two stages: the first one is a lung region segmentation step and is used to exclude irrelevant factors, and the second is a detection and recommendation stage. Under this framework, in the second stage, we develop a dual-children network (DuCN) based on a pre-trained ResNet-18 to simultaneously realize the disease diagnosis and similar case recommendation. Besides, we employ triplet loss and intrapulmonary distance maps to assist the detection, which helps incorporate tiny differences between two images and is conducive to improving the diagnostic accuracy. For each confirmed COVID-19 case, we give similar cases to provide radiologists with diagnosis and treatment references. We conduct experiments on a large publicly available dataset (CC-CCII) and compare the proposed model with state-of-the-art COVID-19 detection methods. The results show that our proposed model achieves a promising clinical performance.
Distinguishing COVID-19 from other flu-like illnesses can be difficult due to ambiguous symptoms and still an initial experience of doctors. Whereas, it is crucial to filter out those sick patients who do not need to be tested for SARS-CoV-2 infectio
n, especially in the event of the overwhelming increase in disease. As a part of the presented research, logistic regression and XGBoost classifiers, that allow for effective screening of patients for COVID-19, were generated. Each of the methods was tuned to achieve an assumed acceptable threshold of negative predictive values during classification. Additionally, an explanation of the obtained classification models was presented. The explanation enables the users to understand what was the basis of the decision made by the model. The obtained classification models provided the basis for the DECODE service (decode.polsl.pl), which can serve as support in screening patients with COVID-19 disease. Moreover, the data set constituting the basis for the analyses performed is made available to the research community. This data set consisting of more than 3,000 examples is based on questionnaires collected at a hospital in Poland.
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
